Prokaryotic expression of Stx1B subunit of escherichia coli O157: H7 used to generate monoclonal antibody

Hybridoma

Volumn 29, Issue 4, 2010, Pages 283-289

  Li, Guangxing ^a   Hong, Jiehua ^a   Ren, Xiaofeng ^a   Yin, Jiechao ^a   Feng, Shuzhang ^b   Huo, Guicheng ^a  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 1G11; UNCLASSIFIED DRUG; VEROTOXIN 1;

ANIMAL EXPERIMENT; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; BIOLOGICAL ACTIVITY; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI O157; EXPRESSION VECTOR; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROKARYOTE; PROTEIN EXPRESSION; RECOMBINANT PLASMID;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI O157; HUMANS; HYBRIDOMAS; IMMUNIZATION; MICE; MICE, INBRED BALB C; PROTEIN SUBUNITS; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SHIGA TOXIN 1;

ANIMALIA; ESCHERICHIA COLI; MUS; PROKARYOTA;

EID: 77955871423     PISSN: 15540014     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.2010.0021     Document Type: Article

References (35)

1. Griffin PM, and Tauxe RV: The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev 1991;13:60-98.
2. Karch H, Bielaszewska M, Bitzan M, and Schmidt H: Epidemiology and diagnosis of Shiga toxin-producing Escherichia coli infections. Diagn Microbiol Infect Dis 1999;34:229-243.
3. Elliott EJ, Robins-Browne RM, O'Loughlin EV, Bennett-Wood V, Bourke J, Henning P, Hogg GG, Knight J, Powell H, and Redmond D: Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features. Arch Dis Child 2001;85:125-131.
4. Tarr PI, Gordon CA, and Chandler WL: Shiga-toxinproducing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005;365:1073-1086.
5. Rivas M, Miliwebsky E, Chinen I, Roldan CD, Balbi L, Garcia B, Fiorilli G, Sosa-Estani S, Kincaid J, Rangel J, and Griffin PM: Characterization and epidemiologic subtyping of Shiga toxin-producing Escherichia coli strains isolated from hemolytic uremic syndrome and diarrhea cases in Argentina. Foodborne Pathog Dis 2006;3:88-96.
6. Bitzan M, Poole R, Mehran M, Sicard E, Brockus C, Thuning-Roberson C, and Rivière M: Safety and pharmacokinetics of chimeric anti-Shiga toxin 1 and anti-Shiga toxin 2 monoclonal antibodies in healthy volunteers. Antimicrob Agents Chemother 2009;53:3081-3087.
7. Easton L: Escherichia coli O157:H7: occurrence, transmission and laboratory detection. Br J Biomed Sci 1997;54:57-64.
8. Tesh VL, and O'Brien AD: The pathogenic mechanisms of Shiga-toxin and the Shiga-like toxin. Mol Microbiol 1991;5: 1817-1822.
9. Bast DJ, Brunton JL, Karmali MA, and Richardson SE: Toxicity and immunogenicity of a verotoxin 1 mutant with reduced globotriaosylceramide receptor binding in rabbits. Infect Immun 1997;65:2019-2028.
10. Stein PE, Boodhoo A, Tyrrell GJ, Brunton JL, and Read RJ: Crystal structure of the cell binding B oligomer of verotoxin-1 from Escherichia coli. Nature 1992;355:748-750.
11. Wolski VM, Soltyk AM, and Brunton JL: Mouse toxicity and cytokine release by verotoxin 1B subunit mutants. Infect Immun 2001;69:579-583.
12. Endo Y, Tsurgi K, Yutsudo T, Takeda Y, Ogasawara T, and Igarashi K: Site of action of a vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. Eur J Biochem 1988;171:45-50.
13. Wadolkowski EA, Burris JA, and O'Brien AD: Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7. Infect Immun 1990;58:2438-2445.
14. Richardson SE, Rotman T, Jay V, Smith C, Becker L, Petric M, Olivieri N, and Karmali M: Experimental verocytotoxemia in rabbits. Infect Immun 1992;60:4154-4167.
15. Zoja C, Corna D, Farina C, Sacchi G, Lingwood C, Doyle M, Padhye VV, Abbate M, and Remmuzzi G: Tissue localization of verotoxin glycolipid receptor determines clinical expression of the disease in rabbits challenged with verotoxin-1. J Lab Clin Med 1992;120:229-238.
16. Sjogren R, Neill R, Rachmilewitz D, and Fritz D: Role of Shiga-like toxin I in bacterial enteritis: comparison between isogenic strains induced in rabbits. Gastroenterology 1994; 106:306-317.
17. Liu J, Sun Y, Feng S, Zhu L, Guo X, and Qi C: Towards an attenuated enterohemorrhagic Escherichia coli O157:H7 vaccine characterized by a deleted ler gene and containing apathogenic Shiga toxins. Vaccine 2009;27:5929-5935.
18. Liu B, Li G, Sui X, Yin J, Wang H, and Ren X: Expression and functional analysis of porcine aminopeptidase N produced in prokaryotic expression system. J Biotechnol 2009;141: 91-96.
19. Li G, Lillehoj HS, and Min W: Production and characterization of monoclonal antibodies reactive with the chicken interleukin-15 receptor alpha chain. Vet Immunol Immunopathol 2001;82:215-227.
20. Newell DG, McBride BW, and Clark SA: Making Monoclonals: A Practical Beginners Guide to the Production and Characterization of Monoclonal Antibodies Against Bacteria and Viruses. Public Health Laboratory Service, London, 1988.
21. Beatty JD, Beatty BG, and Vlahos WG: Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay. J Immunol Methods 1987;100:173-179.
22. Raghava GP, and Agrewala JN: Method for determining the affinity of monoclonal antibody using non-competitive ELISA: a computer program. J Immunoassay 1994;15:115-128.
23. Caprioli A, Morabito S, Brugère H, and Oswald E: Enterohaemorrhagic Escherichia coli: emerging issues on virulence and modes of transmission. Vet Res 2005;36:289-311.
24. Li G, Zeng Y, Yin J, Lillehoj HS, and Ren X: Cloning, prokaryotic expression, and biological analysis of recombinant chicken IFN-g. Hybridoma 2010;29:1-6.
25. Yin J, Li G, Ren X, and Herrler G: Select what you need: a comparative evaluation of the advantages and limitations of frequently used expression systems for foreign genes. J Biotechnol 2007;127:335-347.
26. Hussein HS, and Sakuma T: Prevalence of Shiga toxin-producing Escherichia coli in dairy cattle and their products. J Dairy Sci 2005;88:450-465.
27. Besser TE, Hancock DD, Pritchett LC, McRae EM, Rice DH, and Tarr PI: Duration of detection of fecal excretion of Escherichia coli O157:H7 in cattle. J Infect Dis 1997;175:726-729.
28. Dean-Nystrom EA, Bosworth BT, Cray WC, and Moon HW: Pathogenecity of Escherichia coli O157:H7 in the intestines of neonatal calves. Infect Immun 1997;65:1842-1848.
29. Mechie SC, Chapman PA, and Siddons CA: A fifteen-month study of Escherichia coli O157:H7 in a dairy herd. Epidemiol Infect 1997;118:17-25.
30. Sandhu KS, Clarke RC, McFadden K, Brouwer A, Louie M, Wilson J, Lior H, and Gyles CL: Prevalence of the eaeA gene in verotoxigenic Escherichia coli strains from dairy cattle in Southwest Ontario. Epidemiol Infect 1996;116:1-7.
31. Chiueh L, Liu F, and Shih DY: Prevalence of Shiga toxin producing Escherichia coli in feed and raw milk of domestic cattle and sheep. J Food Drug Anal 2002;10:39-46.
32. Pradel N, Boukhors K, Bertin Y, Forestier C, Martin C, and Livrelli V: Heterogeneity of Shiga toxin-producing Escherichia coli strains isolated from hemolytic-uremic syndrome patients, cattle, and food samples in central France. Appl Environ Microbiol 2001;67:2460-2468.
33. Pradel N, Livrell V, de Champs C, Palcoux J, Reynaud A, Scheutz F, Sirot J, Joly B, and Forestier C: Prevalence and characterization of Shiga toxin-producing Escherichia coli isolated from cattle, food, and children during a one-year prospective study in France. J Clin Microbiol 2000;38:1023-1031.
34. Doyle MP: Escherichia coli O157:H7 and its significance in foods. Int J Food Microbiol 1991;12:289-302.
35. Strockbine NA, Marques LR, Holmes RK, and O'Brien AD: Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli. Infect Immun 1985;50:695-700.